LENZ Therapeutics (LENZ) Change in Acquisitions & Divestments (2022 - 2026)

LENZ Therapeutics (LENZ) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $49.2 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 5.48% year-over-year to $49.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $203.1 million (up 66.49% YoY) and the FY2025 annual result came in at $206.0 million, up 134.31% from the prior year.
• Change in Acquisitions & Divestments advanced to $49.2 million in Q1 2026 per LENZ's latest filing, from $43.3 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $90.0 million in Q3 2022 and bottomed at $1.5 million in Q3 2023.
• The 5-year median for Change in Acquisitions & Divestments is $43.3 million (2025), against an average of $41.2 million.
• The widest annual swing landed in 2023, when Change in Acquisitions & Divestments slumped 98.33%; it then soared 1366.67% in 2024.
• Tracing LENZ's Change in Acquisitions & Divestments over 5 years: stood at $80.2 million in 2022, then plunged by 73.83% to $21.0 million in 2023, then soared by 66.19% to $34.9 million in 2024, then increased by 24.18% to $43.3 million in 2025, then rose by 13.6% to $49.2 million in 2026.
• Per Business Quant, the three latest LENZ Change in Acquisitions & Divestments figures stand at $49.2 million (Q1 2026), $43.3 million (Q4 2025), and $52.4 million (Q3 2025).

Peer Comparison